A study for Subjects with Advanced Non-Small Cell Lung Cancer cured with either Tamibarotene or placebo plus Paclitaxel and Carboplatin as First Line Treatment The primary objective of this study is to determine the progression-free survival and objective response rate (complete + partial responses) of subjects with stage IIIB with pleural effusion or IV non...

• Country None
• organs None
• Specialty None

A study to compare how safe Aldoxorubicin is and how well it works against known treatments in patients with soft tissue sarcoma Estudio para comparar cómo es de segura la aldoxorrubicina y si funciona bien respecto a otros tratamientos conocidos en pacientes con sarcoma de tejido blando The primary objective of this study is to determine the efficacy of administration of aldoxorubicin compared to investigator's choice of treatment in subjects with metastatic, locally advanced, or unr...

• Country None
• organs None
• Specialty None

CytRx INNO-507-P2 : Essai de phase 2 évaluant l’efficacité et la tolérance d’un traitement par tamibarotène chez des patients ayant une leucémie aigüe promyélocytaire. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] A phase II study of oral tamibarotene in acute promyelocytic leukemia patients who have received prior therapy with ATRA and arsenic trioxide (star-1).

• Country France
• organs Leucémies aiguës
• Specialty Chimiothérapie